Pharmacotherapy of the overactive bladder and advances in drug delivery

Clin Obstet Gynecol. 2002 Mar;45(1):205-17. doi: 10.1097/00003081-200203000-00022.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Administration, Intravesical
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Benzhydryl Compounds / pharmacology
  • Benzhydryl Compounds / therapeutic use
  • Botulinum Toxins / therapeutic use
  • Capsaicin / pharmacology
  • Capsaicin / therapeutic use
  • Cholinergic Antagonists / administration & dosage
  • Cholinergic Antagonists / pharmacology
  • Cresols / pharmacology
  • Cresols / therapeutic use
  • Cystitis, Interstitial / drug therapy
  • Diterpenes / pharmacology
  • Diterpenes / therapeutic use
  • Humans
  • Mandelic Acids / pharmacology
  • Neurotoxins / pharmacology
  • Neurotoxins / therapeutic use
  • Phenylpropanolamine*
  • Tolterodine Tartrate
  • Urinary Bladder / drug effects
  • Urinary Bladder Diseases / drug therapy*
  • Urination Disorders / drug therapy*

Substances

  • Antidepressive Agents, Tricyclic
  • Benzhydryl Compounds
  • Cholinergic Antagonists
  • Cresols
  • Diterpenes
  • Mandelic Acids
  • Neurotoxins
  • Phenylpropanolamine
  • Tolterodine Tartrate
  • resiniferatoxin
  • Botulinum Toxins
  • oxybutynin
  • Capsaicin